-
-
-
-
-
-
-
PMGC Holdings secures $40 million equity facility for acquisitions
-
-
-
-
-
-
-
NorthStrive extends AI drug discovery Phase III timeline to Q2 2026
-
-
-
-
-
-
-
PMGC Holdings (ELAB) files for 5M share offering by selling stockholders
-
-
-
-
-
-
-
Northstrive Biosciences (ELAB) completes Phase 1 review for EL-22
-
-
-
-
-
-
-
PMGC Holdings (ELAB) Announces 1:7 Reverse Share Split
-
-
-
-
-
-
-
Elevai Labs (ELAB) Announces Anticipated Name Change to PMGC Holdings, Redomicile to Nevada
-
-
-
-
-
-
-
Elevai Labs (ELAB) Files for 28.37M Share and Warrant Offering
-
422,775 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

